• Blog
  • Organ and Tissue Transplantation Market Growth Analysis

    Organ and Tissue Transplantation Market Growth Analysis

    Organ and Tissue Transplantation Market Growth Analysis
    Report code - SR1426 Delivery - 2 Weeks
    Organ and Tissue Transplantation Market Growth, Trends, Dynamics & Market Insights: 20 See more...

    Market Insights

    The Organ and Tissue Transplantation Market is estimated to grow from USD 13.8 billion in 2020 to USD 23.3 billion by 2026 at a healthy CAGR of 9.3% during the forecast period.

     

    Wish to get a free sample? Register Here

    What is transplantation?

    Transplantation is a complex area of medicine because when tissues or organs are transplanted from one person to another, the recipient’s immune system can reject and destroy the donor tissue or organ and medication would be required to suppress the immune response.

    Key Players

    Key players operating in the Organ and Tissue Transplantation market are-

    • CryoLife, Inc. (US)
    • Folio Biosciences (US)
    • Arthrex (US)
    • Abbvie, Inc. (US)
    • Zimmer Biomet (US)
    • Medtronic PLC (Ireland)
    • Novartis AG (Switzerland)
    • Stryker Corporation (US)
    • BiolifeSolutions, Inc. (US)
    • Teva Pharmaceuticals (Israel).

    Market Dynamics

    Growing demand for tissue and organ transplantation, especially from high-income countries is one of the key countries. Rising prevalence of diseases including cancer, diabetes, renal diseases, cardiovascular diseases, and Alzheimer’s disease have posed a threat of irreversible tissue damage to a large population, across the globe is a key factor boosting the market growth. Moreover, increasing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is likely to offer lucrative opportunities.

    COVID-19 Impact

    The COVID-19 outbreak has moderately affected the organ and tissue transplantation industry. The virus outbreak has turned the lives of people worldwide, with the number of cases increasing rapidly. The COVID-19 crisis has reduced the number of visits to hospitals and surgeries were postponed to curb the spread of the virus, thus affecting the market growth amid the pandemic.

    Segments' Analysis

    Product Trends

    The organ and tissue transplantation market is classified into tissue products, immunosuppressive drugs, and preservation solutions. The tissue products segment held a significant market share in 2020 and is estimated to register a healthy CAGR during the forecast timeline. This is mainly because replacement of cornea, skin, heart valves, bones, nerves, tendons, and veins are the most commonly performed procedures across the globe, which bolsters the segment growth. 

    Regional Trends

    The North American market accounted for a significant share in 2020 and is expected to grow at a substantial CAGR in the following years. This is mainly ascribed to a surge in the number of transplantation surgeries performed, high consumer awareness, presence of excellent healthcare infrastructure, the large presence of a majority of major players, and rise in government and R&D activities, thereby proliferating the regional market growth.

    To get the full scope of the report, Register Here

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Organ and Tissue Transplantation Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The organ and tissue transplantation market is expected to witness an impressive growth of 9.3% CAGR in the coming years.

    CryoLife, Inc. (US), Folio Biosciences (US), Arthrex (US), Abbvie, Inc. (US), Zimmer Biomet (US), Medtronic PLC (Ireland), Novartis AG (Switzerland), Stryker Corporation (US), BiolifeSolu-tions, Inc. (US), and Teva Pharmaceuticals (Israel) are among the key players in the organ and tissue transplantation market.

    The organ and tissue transplantation market size is expected to reach USD 23.3 billion in the foreseeable future.

    The tissue products segment is expected to register a healthy CAGR in the organ and tissue transplantation market in the coming years.

    North America is expected to grow at a substantial CAGR in the organ and tissue transplantation market in the next five years.

    rowing demand for tissue and organ transplantation, especially from high-income countries is one of the key countries. Rising prevalence of diseases including cancer, diabetes, renal diseases, cardiovascular diseases, and Alzheimers disease have posed a threat of irreversible tissue damage to a large population, across the globe is a key factor boosting the market growth.